Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG).
Akyildiz A, Guven DC, Koksal B, Karaoglan BB, Kivrak D, Ismayilov R, Aslan F, Sutcuoglu O, Yazici O, Kadioglu A, Alan O, Majidova N, Erciyestepe M, Ozcan E, Akdag G, Taban H, Kaya AO, Guliyev M, Yildirim N, Sakalar T, Yazilitas D, Unal C, On S, Biter S, Demirci NS, Senler FC, Kemal Y, Halil OD, Gullu I, Aksoy S. Akyildiz A, et al. Among authors: unal c. Eur Arch Otorhinolaryngol. 2024 May 25. doi: 10.1007/s00405-024-08744-4. Online ahead of print. Eur Arch Otorhinolaryngol. 2024. PMID: 38795147
The Relationship of Pathological Response and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant Chemotherapy.
Kayan Tapan T, Çelebi F, Yaghouti K, Ağaçayak F, İlgün S, Soybir G, Alço G, Ak N, Ordu Ç, Özkurt E, Ünal Ç, Kurt S, Öztürk A, İyigün Z, Duymaz T, Özmen V. Kayan Tapan T, et al. Among authors: unal c. Eur J Breast Health. 2024 Apr 1;20(2):117-121. doi: 10.4274/ejbh.galenos.2024.2023-12-5. eCollection 2024 Apr. Eur J Breast Health. 2024. PMID: 38571683 Free PMC article.
Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
Taşçı EŞ, Oyan B, Sönmez Ö, Mutlu AU, Atcı MM, Sakin A, Öner İ, Çınkır HY, Eryılmaz MK, Çağlayan D, Balçık OY, Paksoy N, Karabulut S, Salim DK, Bilir C, Özen M, Özçelik M, Arıcan A, Akagündüz B, İnal A, Aydın D, Özer L, Gülmez A, Turhal NS, Esen SA, Algın E, Akbaş S, İriağaç Y, Şakalar T, Ünal Ç, Er Ö, Seçmeler Ş, Bozkurt M. Taşçı EŞ, et al. Among authors: unal c. BMC Cancer. 2024 Jan 23;24(1):114. doi: 10.1186/s12885-024-11863-0. BMC Cancer. 2024. PMID: 38262962 Free PMC article. No abstract available.
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
Taşçı EŞ, Oyan B, Sönmez Ö, Mutlu AU, Atcı MM, Sakin A, Öner İ, Çınkır HY, Eryılmaz MK, Çağlayan D, Balçık OY, Paksoy N, Karabulut S, Salim DK, Bilir C, Özen M, Özçelik M, Arıcan A, Akagündüz B, İnal A, Aydın D, Özer L, Gülmez A, Turhal NS, Esen SA, Algın E, Akbaş S, İriağaç Y, Şakalar T, Ünal Ç, Er Ö, Seçmeler Ş, Bozkurt M. Taşçı EŞ, et al. Among authors: unal c. BMC Cancer. 2024 Jan 2;24(1):16. doi: 10.1186/s12885-023-11783-5. BMC Cancer. 2024. PMID: 38166764 Free PMC article.
Refusal of the hospitalization: a distressed dilemma in obstetric practice.
Unal C, Fadiloglu E, Cagan M, Ziyadova G, Kaya E, Tanacan A, Beksac MS. Unal C, et al. Ther Adv Reprod Health. 2023 Dec 25;17:26334941231216531. doi: 10.1177/26334941231216531. eCollection 2023 Jan-Dec. Ther Adv Reprod Health. 2023. PMID: 38152477 Free PMC article.
Impact of scoliosis on gestational outcome.
Ünal C, Tanaçan A, Fadiloğlu E, Çağan M, Yücesoy HM, Beksaç MS. Ünal C, et al. J Turk Ger Gynecol Assoc. 2023 Dec 6;24(4):241-245. doi: 10.4274/jtgga.galenos.2023.2022-10-3. J Turk Ger Gynecol Assoc. 2023. PMID: 38054415 Free PMC article.
161 results